What is SLNO's health score?

SOLENO THERAPEUTICS INC (SLNO) has a TradeApes health score of 60 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SLNO's estimated fair value?

Based on our 5-year discounted cash flow model, SOLENO THERAPEUTICS INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is SLNO undervalued or overvalued?

Our model currently rates SLNO as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for SLNO... Refresh in a moment for the full analysis.

SOLENO THERAPEUTICS INC (SLNO)

Healthcare Inconclusive inconclusive healthy

$53.01

Updated: 2026-06-05

TradeApes Score

Financial Strength

85 Strong

Operating Trend

55 Mixed

Relative Value

48 Mixed

Capital Allocation

30 Weak

Risk

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.